Home›Stock Screener›Panacea Biotec›Quarterly Results

Panacea Biotec Quarterly Results

Latest Quarter Net Profit
₹12 Cr
QSept 2026
Quarterly Results

Panacea Biotec quarterly results. In Sept 2026, Panacea Biotec (PANACEABIO) reported revenue ₹199 Cr and net profit ₹12 Cr — revenue +32.7% YoY. View PANACEABIO price range for the annual high/low range and current price position.

PANACEABIO Quarterly Results — Revenue, Profit & EPS Highlights

Panacea Biotec latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore PANACEABIO share price history to track price trends across different timeframes.

  • Revenue of ₹199 Cr in Sept 2026 (+15.7% vs Mar 2026, +32.7% vs Sept 2025)
  • Net Profit of ₹12 Cr in Sept 2026 (+1300.0% vs Mar 2026, +185.7% vs Sept 2025)
  • EBITDA of ₹25 Cr in Sept 2026 (+212.5% vs Mar 2026)
  • Operating Margin of 8.0% in Sept 2026 (+6.0pp vs Mar 2026)
  • Earnings Per Share of ₹1.90 in Sept 2026 (+2275.0% vs Mar 2026)

Panacea Biotec Quarterly Results — Revenue, EBITDA, Net Profit & EPS

PANACEABIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 199 172 207 150 169 15.7% 32.7%
Net Profit (₹ Cr) 12 -1 2 -14 -2 - -
EBITDA (₹ Cr) 25 8 13 -9 9 - -
EPS (₹) 1.90 0.08 0.38 -2.27 -0.31 - -
Operating Margin (%) 8.0% 2.0% 3.0% -13.0% -20.0% - -

PANACEABIO Share Price Trend — 1-Year Movement Across Quarterly Results

Panacea Biotec 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Panacea Biotec share price chart.

Profitability Ratios

Profit Margin 6.0%
EBITDA Margin 12.6%
Operating Margin 8.0%
ROE (Annual) 5.8%

Balance Sheet Highlights

Total Assets ₹1,262 Cr
Total Equity ₹829 Cr
Current Assets ₹ Cr
Current Liabilities ₹85 Cr

Cash Flow Analysis

Operating Cash Flow ₹17 Cr
Investing Cash Flow ₹-41 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹-25 Cr

Current Market Data

Current Price ₹352.85
Exchange NSE
Last Updated Nov 19, 2026

PANACEABIO vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Panacea Biotec latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores